Vaccine-induced immune thrombotic thrombocytopenia: what do we know hitherto?
R Roytenberg, A García-Sastre, W Li - Frontiers in medicine, 2023 - frontiersin.org
Vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis
with thrombocytopenia syndrome, is a catastrophic and life-threatening reaction to …
with thrombocytopenia syndrome, is a catastrophic and life-threatening reaction to …
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC …
B Gigante, JH Levy, E van Gorp, A Bartoloni… - European heart …, 2023 - academic.oup.com
Patients with severe infections and a pre-existing indication for antithrombotic therapy, ie
antiplatelet agents, anticoagulant drugs, or their combinations, require integrated clinical …
antiplatelet agents, anticoagulant drugs, or their combinations, require integrated clinical …
Thrombosis and bleeding in patients with vaccine-induced immune thrombotic thrombocytopenia: a systematic review of published cases
B Clerici, E Pontisso, C Aloise, B Peroni… - Thrombosis and …, 2023 - thieme-connect.com
Introduction Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a highly
prothrombotic reaction to COVID-19 (coronavirus disease 2019) adenoviral vector vaccines …
prothrombotic reaction to COVID-19 (coronavirus disease 2019) adenoviral vector vaccines …
Blood coagulation and thrombotic disorders following SARS-CoV-2 infection and COVID-19 vaccination
Although abundant data confirm the efficacy and safety profile of the developed vaccines
against COVID-19, there are still some concerns regarding vaccination in high-risk …
against COVID-19, there are still some concerns regarding vaccination in high-risk …
[PDF][PDF] Cerebral venous thrombosis after ChAdOx1 nCoV-19 vaccination: a systematic review.
OBJECTIVE: To perform a systematic review of case reports or case series regarding
thrombosis with thrombocytopenia syndrome (TTS) and cerebral venous thrombosis (CVT) …
thrombosis with thrombocytopenia syndrome (TTS) and cerebral venous thrombosis (CVT) …
Development and validation of a novel prognostic model predicting the atrial fibrillation recurrence risk for persistent atrial fibrillation patients treated with nifekalant …
Y Dong, Z Zhai, B Zhu, S Xiao, Y Chen, A Hou… - … Drugs and Therapy, 2023 - Springer
Background This study aimed to establish and assess a prediction model for patients with
persistent atrial fibrillation (AF) treated with nifekalant during the first radiofrequency catheter …
persistent atrial fibrillation (AF) treated with nifekalant during the first radiofrequency catheter …
Vaccine-Induced Immune Thrombotic Thrombocytopenia Two Years Later: Should It Still Be on the Scientific Agenda?
E Petito, P Gresele - Thrombosis and Haemostasis, 2023 - thieme-connect.com
Vaccine-induced immune thrombotic thrombocytopenia (VITT) was recognized around 2
years ago, at the beginning of the anti-SARS-CoV-2 (severe acute respiratory syndrome …
years ago, at the beginning of the anti-SARS-CoV-2 (severe acute respiratory syndrome …
[HTML][HTML] Distinctions between survivors and non-survivors with SARS-CoV-2 vaccine-induced thrombotic thrombocytopenia: A systematic review and meta-analysis
A Castro-Varela, AKG Salas, A Barrios-Ruiz… - Vaccine: X, 2023 - Elsevier
Vaccine-inducing immune thrombocytopenia, thrombosis, and bleeding emerge as
infrequent and potential complications with mortality risk in healthy subjects. However …
infrequent and potential complications with mortality risk in healthy subjects. However …
[HTML][HTML] SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia: A comprehensive review, release 1 (epidemiologic perspective)
More than eight billion vaccine doses have been delivered to battle the COVID-19
pandemic. SARS-CoV-2 vaccines have been carefully developed and proven efficacious as …
pandemic. SARS-CoV-2 vaccines have been carefully developed and proven efficacious as …
The prevalence of deep vein thrombosis and associated risk factors among patients with COVID-19 in the North of Iran
M Yaseri, SS Mortazavi Khatibani, EG Totkaboni… - Future …, 2023 - Taylor & Francis
Aim: We aimed to investigate the associated risk factors of deep vein thrombosis (DVT)
among COVID-19 patients. Materials & methods: In this cross-sectional study the …
among COVID-19 patients. Materials & methods: In this cross-sectional study the …